Skip to main content
    A

    Alaunos Therapeutics Inc (TCRT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.18
    +0.11 (+5.31%)

    Market Cap: $11.45M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    60%(18/30)
    Avg Surprise
    -17.80%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 14
    		$-0.41N/AN/ABeat+11.5%
    Sep 25
    Reported Nov 14
    		$-0.55$0.00N/AMiss+21.9%
    Jun 25
    Reported Aug 14
    		$-0.63N/AN/ABeat+10.7%
    Mar 25
    Reported May 15
    		$-0.67N/AN/ABeat+96.1%
    Dec 24
    Reported Mar 31
    		$-0.46N/AN/ABeat+5.4%
    Sep 24
    Reported Nov 14
    		$-0.70N/AN/ABeat+84.0%
    Jun 24
    Reported Aug 14
    		$-0.71$0.00N/ABeat+88.2%
    Mar 24
    Reported Apr 2
    		$-17.09$-4.50-279.78%Miss-184.8%
    Dec 23
    Reported Mar 5
    		$-0.49$-0.45-8.89%Miss-1125.0%
    Sep 23
    Reported Nov 14
    		$-4.41$-5.25+16.00%Beat+26.5%
    Jun 23
    Reported Aug 14
    		$-6.00$-6.75+11.11%Beat+20.0%
    Mar 23
    Reported May 10
    		$-6.00$-6.60+9.09%Beat+20.0%
    Dec 22
    Reported Mar 7
    		$-0.04$-0.07+42.86%Beat+20.0%
    Sep 22
    Reported Nov 14
    		$-6.00$-10.75+44.19%Beat+63.6%
    Jun 22
    Reported Aug 15
    		$-7.50$-10.25+26.83%Beat+54.5%
    Mar 22
    Reported May 16
    		$-7.50$-9.90+24.24%Beat+50.0%
    Dec 21
    Reported Mar 30
    		$-0.05$-0.08+37.50%Beat+54.5%
    Sep 21
    Reported Nov 8
    		$-16.50$-18.86+12.51%Beat-10.0%
    Jun 21
    Reported Aug 13
    		$-16.50$-17.57+6.09%Beat-22.2%
    Mar 21
    Reported May 6
    		$-15.00$-15.81+5.12%Beat-11.1%
    Dec 20
    Reported Feb 25
    		$-0.11$-0.10-10.00%Miss-22.2%
    Sep 20
    Reported Nov 5
    		$-15.00$-13.49-11.19%Miss+76.7%
    Jun 20
    Reported Aug 6
    		$-13.50$-13.75+1.82%Beat+0.0%
    Mar 20
    Reported Apr 29
    		$-13.50$-12.75-5.88%Miss-12.5%
    Dec 19
    Reported Mar 2
    		$-0.09$-0.08-12.50%Miss-12.5%
    Sep 19
    Reported Nov 7
    		$-64.50$-13.50-377.78%Miss-230.8%
    Jun 19
    Reported Aug 8
    		$-13.50$-12.24-10.29%Miss+25.0%
    Mar 19
    Reported May 8
    		$-12.00$-12.30+2.44%Beat+46.7%
    Dec 18
    Reported Mar 5
    		$-0.08$-0.11+27.27%Beat+38.5%
    Sep 18
    Reported Nov 9
    		$-19.50$-16.73-16.56%Miss+0.0%
    Jun 18
    Reported Aug 8
    		$-18.00$-18.52+2.81%Beat+7.7%
    Mar 18
    Reported Apr 30
    		$-22.50$-19.06-18.05%Miss+0.0%
    Dec 17
    Reported Mar 1
    		$-0.13$-0.14+7.14%Beat-18.2%
    Sep 17
    Reported Nov 6
    		$-19.50$-20.29+3.89%Beat-
    Jun 17
    Reported Jul 31
    		$-19.50$-18.43-5.81%Miss-
    Mar 17
    Reported May 1
    		$-22.50$-14.22-58.23%Miss-
    Dec 16
    Reported Feb 16
    		$-0.11$-0.11+0.00%Beat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-135233.00%
    ROE-185.90%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio0.77xQuick Ratio0.77x
    Trading Statistics
    Beta-0.87Avg Volume17.00M
    52-Week High$4.5052-Week Low$0.72

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.31
    SMA 20$1.20
    SMA 50$1.52
    SMA 200$2.37
    EMA 10$1.57
    EMA 20$1.40
    EMA 50$1.51
    EMA 200$2.16

    MACD

    Line: 0.11Signal: -0.08Hist: 0.19

    ADX

    ADX: 56.9+DI: 44.8-DI: 6.8

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down72.0
    PSAR$1.08

    Bollinger Bands

    Upper Band$2.36
    Lower Band$0.04
    %B Position19328%(Upper)
    Band Width0.92

    RSI (14-Day)

    Neutral
    61.7

    Momentum Oscillators

    Stoch %K46.9
    Stoch %D48.5
    Williams %R-60.3
    ROC (10d)137.0%
    Momentum1.26
    CCI (20d)139.0
    MFI (14d)77.7

    Volatility Measures

    ATR (14d)$0.51(23.4%)
    StdDev (20d)0.58
    Hist Vol711.2%(High)

    Volume Flow

    VWAP$2.12
    OBV186.9M
    AD Line-47.6M
    CMF (20d)-0.128

    Volume Metrics

    Avg Vol (20d)17.9M
    Vol Ratio0.4x(Low)
    VWMA (20d)$2.63

    Pivot Points

    R3$6.20
    R2$5.30
    R1$3.69
    Pivot Point$2.78
    S1$1.17
    S2$0.27
    S3$-1.35

    Advanced Oscillators

    TSI10.37
    Ultimate Osc41.9
    KST-124.93

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$3,000$0$0$2,000$5,000$0$4,000$1,000$1,000$0
    Cost of Revenue$0$0$-185,000$0$0$0N/A$0$0$0N/A$0
    Gross Profit$0$0$3,000$0$0$2,000$5,000$0$4,000$1,000$1,000$0
    Operating Expenses$952,000$1.01M$910,000$1.19M$1.04M$1.09M$759,000$1.15M$1.17M$1.74M$7.95M$8.66M
    R&D$388,000$427,000$362,000$469,000$185,000$347,000$-87,000$143,000$180,000$126,000$933,000$3.66M
    SG&A$564,000$585,000$548,000$718,000$854,000$747,000$846,000$1.01M$990,000$1.62M$2.43M$3.58M
    Operating Income$-952,000$-1,012,000$-907,000$-1,187,000$-1,039,000$-1,092,000$-754,000$-1,150,000$-1,166,000$-1,742,000$-7,949,000$-8,664,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$0$0$0$0$12,000$0$0$0$0$0$0$0
    Income Before Tax$-952,000$-1,006,000$-862,000$-1,159,000$-1,051,000$-1,073,000$-741,000$-1,127,000$-1,129,000$-1,682,000$-7,843,000$-8,476,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-952,000$-1,006,000$-893,000$-1,159,000$-1,051,000$-1,073,000$-741,000$-1,127,000$-1,129,000$-1,682,000$-7,843,000$-8,476,000
    EBITDA$-943,000$-998,000$-855,000$-1,159,000$-1,051,000$-1,073,000$-742,000$-1,127,000$-1,129,000$-1,682,000$-7,602,000$-7,797,000
    EBIT$-952,000$-1,006,000$-862,000$-1,159,000$-1,051,000$-1,073,000$-741,000$-1,127,000$-1,129,000$-1,682,000$-7,843,000$-8,476,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TCRT

    News

    Form 13D/A Alaunos Therapeutics For: 15 October By Investing.com

    This article from Investing.com reports the filing of a Form 13D/A for Alaunos Therapeutics on October 15. The brief piece includes the stock symbol TCRT...

    Investing.com Canada•10/15/26•Neutral

    Two 9.99% holders agree to back merger votes in Alaunos (TCRT)'s conditional repurchase deal.

    Alaunos Therapeutics (TCRT) has announced a share repurchase and voting agreement in conjunction with its merger with Velaris Therapeutics. Two significant shareholders...

    Stock Titan•10/15/26•Somewhat-Bullish

    Gibson Dunn steers biotech company acquisition

    Gibson Dunn advised Velaris Therapeutics on its acquisition by Alaunos Therapeutics, which completed on October 13. This acquisition combines the companies' portfolios...

    ICLG•10/15/26•Bullish

    TCRT Stock Soars As Velaris Deal Transforms Alaunos

    Alaunos Therapeutics Inc. (TCRT) stock surged over 100% following its acquisition of Velaris Therapeutics and a successful $350 million private placement. This deal adds a new pipeline of cardiopulmonary disease...

    Timothy Sykes•10/14/26•Bullish

    TCRT Stock Soars As Velaris Deal Transforms Alaunos

    Alaunos Therapeutics Inc. (NASDAQ: TCRT) saw its stock price surge following the acquisition of Velaris Therapeutics and a significant $350 million private placement. This deal expands Alaunos' pipeline with new...

    www.timothysykes.com•10/14/26•Bullish

    TCRT Valuation and Fair Value

    Forward P/E
    18.5x
    PEG
    0.6x
    P/B
    8.1x
    See GNG's fair value

    TCRT Profitability: Margins, ROIC and FCF

    Operating margin
    -135233.0%
    Net margin
    0.0%
    ROE
    -185.9%
    FCF margin
    -94166.7%

    TCRT Competitors

    CompanyTicker
    Tempest Therapeutics IncTPST
    Kiora Pharmaceuticals IncKPRX
    Intensity Therapeutics, Inc. Common stockINTS
    Ensysce Biosciences IncENSC
    Passage Bio IncPASG
    Phio Pharmaceuticals CorpPHIO
    In8bio IncINAB
    Cytosorbents CrpCTSO

    Sector: Healthcare

    TCRT Bull Case vs Bear Case

    Bear case

    • TCRT's quarterly revenue changed -25.0% year over year.

    TCRT Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -34.9%

    Frequently Asked Questions About TCRT

    Does TCRT pay dividends?

    Alaunos Therapeutics Inc (TCRT) does not currently pay a regular dividend.

    What is TCRT's market cap?

    Alaunos Therapeutics Inc (TCRT) has a market capitalization of $11.45M with a current stock price of $2.18.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In